Related Experiment Video
Updated: Mar 24, 2026
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.9K
Sugar epitopes as potential universal disease transmission blocking targets
Rhoel R Dinglasan1, Jesús G Valenzuela, Abdu F Azad
1Department of Microbiology and Immunology, University of Maryland School of Medicine, 20 Penn Street, Baltimore, MD 21201, USA.
Insect Biochemistry and Molecular Biology
|December 21, 2004
Summary
Researchers identified a conserved carbohydrate target in arthropod vectors for developing broad-spectrum transmission blocking vaccines (TBVs). This target, a specific glycan structure, could lead to new vaccines against vector-borne diseases.
Area of Science:
- Immunology
- Glycobiology
- Vector-borne disease research
Background:
- Transmission blocking vaccines (TBVs) are promising for preventing vector-borne diseases.
- Developing specific anti-pathogen TBVs for each disease is impractical.
- A conserved target across multiple arthropod vectors is needed for broader vaccine applicability.
Purpose of the Study:
- To identify conserved carbohydrate targets in arthropod vector midguts for TBV development.
- To characterize the epitope recognized by the anti-carbohydrate monoclonal antibody MG96.
Main Methods:
- Screening using a novel GlycoChip glycan array.
- Competition ELISA and immunoblotting with lectins (Con A, Jacalin, Wheat-germ agglutinin).
- Enzyme deglycosylation of mosquito midgut lysates.
Main Results:
- The monoclonal antibody MG96 preferentially recognized D-mannose (alpha) and type II lactosamine disaccharide.
- Jacalin lectin effectively inhibited MG96 binding, suggesting shared recognition of D-mannose (alpha) and T antigen.
- MG96 recognizes a discontinuous glycotope: Manalpha1-6 proximal to Galbeta1-4GlcNAc-alpha-O-R on O-linked oligosaccharides.
Conclusions:
- A conserved glycotope composed of Manalpha1-6 and Galbeta1-4GlcNAc-alpha-O-R on arthropod vector midguts has been identified.
- This glycotope represents a potential target for developing broad-spectrum transmission blocking vaccines.
- The findings pave the way for novel vaccine strategies against diverse vector-borne pathogens.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
00:42Cross-reactivity
33.8K
Overview
33.8K
01:27Glucose Transporters
28.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.2K